nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production
|
Corona, Angela |
|
|
198 |
C |
p. |
artikel |
2 |
Editorial Board
|
|
|
|
198 |
C |
p. |
artikel |
3 |
Endogenous cathelicidin is required for protection against ZIKV-caused testis damage via inactivating virons
|
Liu, Zhen |
|
|
198 |
C |
p. |
artikel |
4 |
5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis
|
Zhao, Jianyuan |
|
|
198 |
C |
p. |
artikel |
5 |
Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method
|
Verrier, Eloi R. |
|
|
198 |
C |
p. |
artikel |
6 |
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
|
Vangeel, Laura |
|
|
198 |
C |
p. |
artikel |
7 |
RNA-Binding motif protein 38 (RBM38) mediates HBV pgRNA packaging into the nucleocapsid
|
Yao, Yongxuan |
|
|
198 |
C |
p. |
artikel |
8 |
Subcutaneous remdesivir administration prevents interstitial pneumonia in rhesus macaques inoculated with SARS-CoV-2
|
Williamson, Brandi N. |
|
|
198 |
C |
p. |
artikel |
9 |
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
|
Abdelnabi, Rana |
|
|
198 |
C |
p. |
artikel |
10 |
Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis
|
Focosi, Daniele |
|
|
198 |
C |
p. |
artikel |